PDCD1 and neoplasm: Bicarbonate administration was added on to the treatment regimen involving anti-PD-1 antibodies, where the combination showed improved antitumor response in different tumor types to indicate that reversing tumor acidity could be a better treatment option in immune checkpoint blockade therapies.